Studies conducted on 196 people show the vaccine shot is more than 94% effective at protecting people from becoming ill with the virus.
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Military confirms use of AI in airstrikes in Middle East, highlighting its growing role in combat operations & future of warfare.
The collective shedding of billions of pounds thanks to GLP-1 drugs is poised reshuffle trillions of dollars in the stock market and economy.
Aventa Genomics, a joint venture of Arima Genomics and Protean BioDiagnostics, launched the Aventa FusionPlus test for patients with solid cancers.
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Cannabis is widely used by patients with cancer to help with cancer symptoms and treatment side effects. Though cannabis has immunomodulatory effects, and its consumption…
/PRNewswire-PRWeb/ — Protean BioDiagnostics is proud to announce its partnership with Travera. As one of Travera’s first Center of Excellence, the partnership…
Protean’s new partnership with Travera will bring expanded treatment options to advanced carcinoma patients and their physicians.
ChromaCode has entered into a partnership with Protean BioDiagnostic for the launch of a non-small cell lung cancer (NSCLC) assay in the US.
